Latest news
Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:30:00 GMTCAD-1005 Phase 2 Data Show >25% Absolute Reduction in Thrombotic Events - Stock TitanStock Titan · Mon, 03 Aug 2026 12:30:00 GMT